HemaSphere (Jun 2022)

P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL

  • A. Koviazin,
  • L. Filatova,
  • I. Zyuzgin,
  • A. Artemyeva,
  • M. Motalkina,
  • Y. Chudinovskikh,
  • S. Volchenkov,
  • I. Poliatskin,
  • E. Dobrovolskaya,
  • S. Shalaev,
  • I. Ishmatova,
  • A. Zverkova,
  • D. Burda,
  • S. Elkhova,
  • T. Semiglazova

DOI
https://doi.org/10.1097/01.HS9.0000848264.70663.5a
Journal volume & issue
Vol. 6
pp. 1235 – 1236

Abstract

Read online

No abstracts available.